FibroBiologics executive buys $19,000 in company stock By Investing.com
FibroBiologics, Inc. (NASDAQ:FBLG) reported that its Chief Scientific Officer, Khoja Hamid, has purchased additional shares of the company’s common stock. The transaction, which took place on August 12, 2024, involved the acquisition of 10,000 shares at a price of $1.90 per share, amounting to a total investment of $19,000. This recent purchase by the executive […]









